期刊文献+

应用EDSS系统评价高压氧治疗多发性硬化患者的临床疗效 被引量:3

EDSS is available in assessment the effects of hyperbaric oxygen in multiple sclerosis
下载PDF
导出
摘要 目的观察高压氧(Hyperbaric Oxygen,HBO)对多发性硬化(Multiple sclerosis,MS)患者神经功能改善的临床疗效。方法采用随机双盲抽样分组将101例经过磁共振、腰椎穿刺术、诱发电位确诊的多发性硬化患者分为对照组50例和病例组51例,两组患者除常规治疗外,对照组给予氧仓不加压吸氧;病例组则给予高压氧治疗,并应用EDSS(Expanded disability status scale,EDSS)评分评估MS患者高压氧治疗前后的神经功能情况。结果高压氧治疗组EDSS评分改善情况明显优于对照组(P<0.05)。结论早期、规律的应用高压氧对多发性硬化患者的治疗有明显的临床疗效。 Objective To observe the improvement of Multiple Sclerosis (Multiple sclerosis, MS) neurological function by after treatment by Hyperbaric Oxygen. Methods Adopt randomized double-blind sampling a group of 101 patients who diagnosed by MRI, lumbar puncture and evoked potential as Multiple Sclerosis divided into a control group of 50 patients, case group of 51 patients, use the EDSS (Expanded Disability status scale, EDSS) score to assess nerve function before and after the hyperbaric oxygen therapy. Results The improvement of EDSS score of case group signifi- cantly better than the control group. Conclusion The early, regular use of hyperbaric oxygen in the treatment of multi- ple sclerosis has a clear benefit.
出处 《西部医学》 2014年第1期74-76,共3页 Medical Journal of West China
关键词 多发性硬化 高压氧 EDSS评分 Multiple Sclerosis Hyperbaric Oxygen EDSS score
  • 相关文献

参考文献8

  • 1Evans J. Epidemiology in practice:randomised controlled trials[J].Community Eye Health,1998,(26):26-27.
  • 2John F. Kurtzke Rating Neurologic impairment in Multiple Sclerosis an expanded disability status scale (EDSS)[J].{H}NEUROLOGY,1983.1444-1453.
  • 3吴江.神经病学[M]{H}北京:人民卫生出版社,2008231.
  • 4Tibbles PM,Edelsberg JS. Hyperbaric-oxygen therapy[J].{H}New England Journal of Medicine,1996,(25):1642-1648.
  • 5Sanchez EC. Hyperbaric oxygenation in peripheral nerve repair and Regeneration[J].{H}Neurological Research,2007,(02):184-198.
  • 6Nie H,Xiong L,Lao N. Hyperbaric oxygen preconditioning induces tolerance against spinal cord ischemia by upregulation of antioxidant enzymes in rabbits[J].{H}Journal of Cerebral Blood Flow and Metabolism,2006,(05):666-674.
  • 7Bosco G,IonadiA,PanicoS. Effects of hypoxia on the circadian patterns in men[J].{H}High Altitude Medicine & Biology,2003,(03):305-318.doi:10.1089/152702903769192269.
  • 8Hansen J,Sander M. Sympathetic neural over activity in healthy humans after prolonged exposure to hypobaric hyoxia[J].{H}JOURNAL OF PHYSIOLOGY,2003.921-929.

同被引文献41

  • 1JADIDI-NIARAGH F, MIRSHAFIEY A. Histamine and histamine re- ceptors in pathogenesis and treatmerlt of multiple sclerosis [ J ]. Neu- ropharmacology,2010,59 ( 3 ) : 180-189.
  • 2POLMAN C H, REINGOLD S C, BANWELL B, et al. Diagnostic cri- teria for multiple sclerosis: 2010 revisions to the McDonald criteria [ J ]. Ann Neurol,2011,69 ( 2 ) :292-302.
  • 3KURTZKE J F. Rating neurologlc impairment in multiple-sclerosis-an expanded disability status scale ( EDSS ) [ J ]. Neurology, 1983,33 (11) :1444-1452.
  • 4MARTINS T B, ROSE J W, JASKOWSKI T D, et al. Analysis of proinflammatory and anti-inflammatory cytokine serum concentrations in patients with multiple sclerosis by using a multiplexed immunoas- say[ J]. Am J Clin Pathol,2011,136 (5) :696-704.
  • 5SALIGRAMA N,CASE L K,DEL RIO R,et al. Systemic lack of ca- nonical histamine receptor signaling results in increased resistance to autoimmune encephalomyelitis [ J ]. J Immunol, 2013,191 ( 2 ) : 614- 622.
  • 6KALLWEIT U, ARITAKE K, BASSETH C L, et al. Elevated CSF histamine levels in multiple sclerosis patients [ J ]. Fluids Barriers CNS,2013,10(10) :19.
  • 7TUOMISTO L, KILPELMNEN H, RIEKKINEN P. Histamine and histamine-N-methyltransferase in the CSF of patients with multiple sclerosis[ J]. Agents Actions, 1983, 13 (2-3) : 255-257.
  • 8KRITAS S K, SAGGINI A, CERULLI G, et al. Impact of mast cells on multiple sclerosis : inhibitory effect of natalizumab [ J ]. Int J Im- munopathol Pharmaco1,2014,27 (3) :331-335.
  • 9CODARRI L, GYULVESZI G, TOSEVSKI V, et al. RORsIT drives production of the cytokine GM-CSF in helper T ceils, which is es- sential for the effector phase of autoimmune neuminflammation [ J ]. Nat Immunol,2011,12(6) :560-567.
  • 10HAAS H L,SERGEEVA O A,SELBACH O. Histamine in the nerv- ous system[ J ]. Physiological reviews ,2008,88 (3) : 1183-1241. doi : 10.1152/physrev. 00043.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部